Home
K2 HealthVentures Equity Trust reported a 2.4% stake in Alto Neuroscience ANRO · 788,995 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 2.4%
- Last report
- 5.6% · filed 25/05/15
- Shares held
- 788,995 sh
- Class
- Common Stock, $0.0001 par value per share
- Event date
- 25/12/31
- Filed
- 26/02/17
2.4% stake · below 5%
- Stake
- 2.4%
- Last report
- 5.6%
- Since last report
- −3.2pp
Alto Neuroscience trades, last 26 weeks
What else happened in Alto Neuroscience around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30K2 HealthVentures Equity Trust's other 5% stake reports
- K2 HealthVentures Equity Trust
5% stakeNeumora Therapeutics
5% stakeNeumora Therapeutics
NMRA
3.1% stake
5,790,453 sh
3.1% stake
Filed 05/15
- K2 HealthVentures Equity Trust
5% stakeNeumora Therapeutics
5% stakeNeumora Therapeutics
NMRA
5.01% stake
8,997,035 sh
5.01% stake
Filed 02/17
- K2 HealthVentures Equity Trust
5% stakeNeumora Therapeutics
5% stakeNeumora Therapeutics
NMRA
6.6% stake
11,397,310 sh
6.6% stake
Filed 25/08/11
- K2 HealthVentures Equity Trust
5% stakeAlto Neuroscience
5% stakeAlto Neuroscience
ANRO
5.6% stake
1,617,855 sh
5.6% stake
Filed 25/05/15
